Review article · 2019
Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins
Bioanalysis, 11(17), 1631–1643 · Published 18 June 2019 · DOI 10.4155/bio-2018-0246
In brief
“Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins” is a 2019 review article by Sophie Tourdot and Timothy Paul Hickling, published in Bioanalysis. OpenAlex counts 41 citations as of 20 November 2026, which puts it in the top 5% of works published in 2019 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 41
- Most cited in
- 2020 (10)
- Field-weighted impact
- 0.51
- References
- 131
- Authors
- 2
Abstract
Therapeutic protein drugs have significantly improved the management of many severe and chronic diseases. However, their development and optimal clinical application are complicated by the induction of unwanted immune responses. Therapeutic protein-induced antidrug antibodies can alter drug pharmacokinetics and pharmacodynamics leading to impaired efficacy and occasionally serious safety issues. There has been a growing interest… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tourdot, S., & Hickling, T. P. (2019). Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins. Bioanalysis, 11(17), 1631–1643. https://doi.org/10.4155/bio-2018-0246
MLA 9
Tourdot, Sophie, and Timothy Paul Hickling. “Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins.” Bioanalysis, vol. 11, no. 17, 2019, pp. 1631–1643. https://doi.org/10.4155/bio-2018-0246.
Chicago
Tourdot, Sophie and Timothy Paul Hickling. 2019. “Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins.” Bioanalysis 11 (17): 1631–1643. https://doi.org/10.4155/bio-2018-0246.
Harvard
Tourdot, S. and Hickling, T. P. (2019) ‘Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins’, Bioanalysis, 11(17), pp. 1631–1643. doi:10.4155/bio-2018-0246.
IEEE
S. Tourdot and T. P. Hickling, “Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins,” Bioanalysis, vol. 11, no. 17, pp. 1631–1643, 2019, doi: 10.4155/bio-2018-0246.
BibTeX
@article{tourdot2019nonclinical,
title = {{Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins}},
author = {Tourdot, Sophie and Hickling, Timothy Paul},
journal = {Bioanalysis},
year = {2019},
volume = {11},
number = {17},
pages = {1631--1643},
doi = {10.4155/bio-2018-0246},
url = {https://doi.org/10.4155/bio-2018-0246}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 3 | |
| 2020 | 10 | |
| 2021 | 5 | |
| 2022 | 7 | |
| 2023 | 4 | |
| 2024 | 3 | |
| 2025 | 5 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.51: it has been cited 0.51 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- therapeutic proteins
- immunogenicity
- antidrug antibodies
- pharmacokinetics
- pharmacodynamics
- in vivo models
- immunogenicity assays
- molecular design
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Tourdot, S., & Hickling, T. P. (2019). Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins. Bioanalysis, 11(17), 1631–1643. https://doi.org/10.4155/bio-2018-0246
How many times has this paper been cited?
41 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Sophie Tourdot, Timothy Paul Hickling.
What is the DOI of this paper?
10.4155/bio-2018-0246, permanently at https://doi.org/10.4155/bio-2018-0246. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.